| 【Sector Research】China Capital Goods – Impact of power suspension on factory production |
| 【Fixed Income Research】EVERRE – How far can the spill-over reach? |
| 【公司研究】百勝中國 (9987 HK) – 長線增長指引符合預期，但咖啡業務可加速擴張 |
| 【Company Research】I-Mab BioPharma (IMAB US) – CD73 confirmed as a promising target for cancer immunotherapy |
| 【Company Research】CG Services (6098 HK) – Acquisition of R&F Property Services: quick wrap up is the key |
| 【Sector Research】China Express Delivery Sector – Easing ASP pressure in Aug to drive sector rebound |
| 【Company Research】HUTCHMED (13 HK) – A home-grown, global-facing Biopharma |
| 【公司研究】百勝中國 (9987 HK) – 疫情讓利潤再次受壓，但中期展望保持樂觀 |
| 【Sector Research】China Technology Sector – Apple Launch Event: iPhone 13/Watch 7 largely inline; no new AirPods 3 slightly disappointing |
| 【Company Research】AK Medical (1789 HK) – Big winner in National VBP |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
